Prenatal pill vs gummy: which boosts iron better in pregnancy?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be able to give written informed consent. * Healthy pregnant women between 21- 40 years of age (inclusive). * Pregnant women in the second trimester of pregnancy (gestational age of 14-19 weeks). * Willing to consume the Study Product daily for the duration of the study. Exclusion Criteria: * History of drug or alcohol abuse * Is hypersensitive to any of the contents of the study product, that would preclude intake of the study products. * Has any significant acute or chronic coexisting health conditions that would prevent them from fulfilling the study requirements, put the Participant at risk, or would confound the interpretation of the study results as judged by the investigator on the basis of medical history. * Severe nausea and vomiting in the first trimester, including hyperemesis gravidarum (HG) * Inability to tolerate oral supplement intake due to gastrointestinal symptoms during the first trimester of pregnancy * Prior Pregnancy Complications (gestational diabetes (GD), HG, or pre-eclampsia, NTDs (Neural Tube Defects)) * Current pregnancy complications (GD, Iron Deficiency Anemia) * Hypertension * Diabetes mellitus * Cardiovascular disease * Class II/III obesity (defined as BMI ≥35.0 Kg/m2) * Malabsorption syndromes (e.g., celiac disease, inflammatory bowel disease) * Severe anemia or iron overload disorders * Thyroid disorders * Current or recent (in the past 12 weeks prior to Visit 1) use of a medication that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results, as judged by the investigator. Prohibited medications include: Medications that contain fat-soluble vitamins A, E, or K in high doses \- Current or recent (in the past 12 weeks prior to Visit 1) use of prohibited nutritional or non-nutritional supplements that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results as judged by the investigator.